Law ❯ Litigation ❯ Intellectual Property
False Advertising Disparagement Deceptive Advertising Consumer Protection Fraudulent Advertising Non-Consensual Content Monopoly Law Digital Advertising Cultural Heritage
Novo says Lilly’s nationwide commercials mislead patients by comparing Lilly’s top doses to lower doses of Novo drugs and has asked a federal court to intervene.